Company Filing History:
Years Active: 2013-2020
Title: Ikuo Chiba: Innovator in Aquatic Organism Eradication
Introduction
Ikuo Chiba is a notable inventor based in Ishinomaki, Japan. He has made significant contributions to the field of aquatic organism management through his innovative inventions. With a total of 2 patents, Chiba's work focuses on environmentally friendly solutions for treating ballast water.
Latest Patents
Chiba's latest patents include a multi-tube nozzle designed for eradicating harmful aquatic organisms. This innovative nozzle allows for the direct intake of water into culture or ballast tanks without the need for pretreatment or chemicals. The design features at least three adjacent nozzle tubes, each with a unique structure that enhances its effectiveness. The nozzle's throat section has a smallest inner diameter, which contributes to its ability to physically kill harmful organisms while maintaining water flow.
Another significant patent involves ballast water treatment equipment that decomposes fungicides present in ballast water. This invention aims to reduce the reliance on fungicide adsorbing materials, thereby promoting a more sustainable approach to ballast water management.
Career Highlights
Throughout his career, Ikuo Chiba has worked with esteemed institutions such as Tohoku University and Kowa Kogyo Co., Ltd. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in aquatic treatment technologies.
Collaborations
Chiba has collaborated with notable colleagues, including Akihiro Kijima and Yasuaki Kohama. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field.
Conclusion
Ikuo Chiba's contributions to the field of aquatic organism management through his innovative patents demonstrate his commitment to environmental sustainability. His work not only addresses pressing ecological challenges but also paves the way for future advancements in water treatment technologies.